BILLS-117hr3537rds.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (16)
02:45 Dec 17, 2021
1ST SESSION H. R. 3537
later than 4 years
2021
September 30, 2026
DECEMBER 9, 2021
one year
later than 6 months
2026
December 8
days
42 U.S.C. 284a
5-year
1965
later than one year
1986
EVENT (1)
the ‘‘Accelerating Access
FAC (5)
PO 00000
Frm 00010
PO 00000
Frm 00002
PO 00000
Frm 00001
PO 00000
Frm 00012
PO 00000
Frm 00007
GPE (2)
THE UNITED STATES
the United States of America
NORP (1)
lish
ORG (38)
DSKJLVW7X2PROD with BILLS
SEC
Federal
Food, Drug
the Federal Food, Drug
U.S.C.
the Food and Drug Adminis-
the Public Health Service Act
Health and Human Services
the Food and Drug Administration
the House of Representatives
ALS
Senate
the Food and Drug
Labor
the Small Business Act
Food and Drug Administration
Health
the Comptroller General
Committee
Congress
non-Federal
Health, Education
HHS PUBLIC-PRIVATE PARTNERSHIP
House of Representa-
the Food and Drug Ad-
5
FUNDS.—A
the Commissioner of Food and Drugs
the Committee on Energy
the Department of
16
Health and Human Services
Human Services
the National Institutes of Health
Drug Administration
GAO
APPROPRIATIONS
the Internal Revenue Code
PERSON (1)
CHERYL L. JOHNSON
Topic Classifications
congressional legislation
98.0%
government oversight
50.1%
public health
42.0%
Extracted Keywords
cure amyotrophic
lateral sclerosis
amyotrophic
amyotrophic lateral
sclerosis
lateral
investigational
expanded access
cure
rds pbinns
bills rds
rds
clinical trials
trials
diagnosis
Forensic Analysis
PDF Metadata
- Creator
- U.S. Gov. Printing Office -- G.S.D.D.
- ModDate
- D:20221229133607Z
- Producer
- Acrobat Distiller 21.0 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20211217025746-05'00'
Sentiment
Polarity
Neutral
-0.018
Subjectivity
43%
Objective